Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIANON Systems is a premier provider of anatomic pathology and molecular diagnostic services, specializing in oncology, urology, and gastroenterology. Founded in 1983, the company established itself as a leader in the diagnostic laboratory industry by providing high-quality, sub-specialized testing for physicians and hospitals. DIANON's service offerings include sophisticated cancer diagnostics, such as hematopathology and prostate pathology, which are critical for patient management. In 2003, the company was acquired by LabCorp for approximately $598 million. Today, it operates as a specialized pathology brand within LabCorp's extensive diagnostic network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIANON Systems.